WallStreetZenWallStreetZen

How to Buy Cardlytics Stock

Cardlytics Inc

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom.

Cardlytics stock last closed at $14.49, down 1.02% from the previous day, and has increased 457.31% in one year. It has overperformed other stocks in the Advertising Agencies industry by 4.45 percentage points. Cardlytics stock is currently +415.66% from its 52-week low of $2.81, and -29.39% from its 52-week high of $20.52.

There are currently 44.11M shares of CDLX outstanding. The market cap of CDLX is $639.14M. In the past 24 hours, 3.43M CDLX shares were traded.

How to Buy Cardlytics Stock

Wondering how to invest in Cardlytics stock? Here's how.
  1. Decide where to buy Cardlytics stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you choose where to buy Cardlytics stock.
  2. Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Fund your brokerage account: Select your method of payment and add your info.
  4. Analyze Cardlytics stock: The Cardlytics ticker symbol is CDLX. Is Cardlytics stock a good investment? Should you buy shares of CDLX? How do CDLX's underlying business fundamentals look? Do top analysts think Cardlytics is a good buy? Why has CDLX's stock price moved recently? (Hint: Our stock research tools can help you evaluate if CDLX is a good stock to buy).
  5. Make your CDLX buy order: Decide if you will purchase CDLX shares at the current market price or use a limit order to purchase CDLX stock at a given price.
  6. Get updates on your investment in CDLX: Create a watchlist to important updates regarding your new investment in Cardlytics stock.

Step 1: Decide where to buy Cardlytics stock

You need an online brokerage account to access the NASDAQ market and buy CDLX stock.

A brokerage account allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best online stock brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world financial markets: From Tech to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by signing up for an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've chosen the right brokerage, the next step is to fill out some personal info so you can invest in CDLX today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to create a new trading account.
  1. Submit your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've opened your account on the highest rated app to buy and sell stocks, your next step is to transfer the money for your investment:

Check out the walkthrough below for more details transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Cardlytics stock

Once you have decided on the best place to buy Cardlytics stock, it's very important to analyze their stock before you buy, so you actually wrap your head around the risk and upside.

Cardlytics quick stats

CDLX Price
$14.49
1w %
-4.92%
1y %
457.31%
5y %
-12.29%
P/E
-3.93x
P/B
4.74x
P/S
1.71x
PEG
N/A
Revenue
$309.20M
Earnings
-$134.70M
Fore. Rev. Growth
44.4%
Fore. Earn. Growth
N/A
Market Cap
$639.14M
Next Earnings
May 2, 2024
Next Dividend
N/A

Cardlytics Overview

WallStreetZen was designed to help everyday investors do more accurate fundamental analysis.

You can see all of the due diligence checks on CDLX's stock page.

Is CDLX stock overvalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CDLX's intrinsic value.

Using relative valuations methods:

  • CDLX may be overvalued based on its P/B ratio of 4.74x, relative to Advertising Agencies industry P/B ratio of 3.44x

You can access additional valuation analysis on CDLX's stock here.

CDLX Financial Health Overview

Positive Health Checks:

  • CDLX has $91.83M in cash and short term investments. This is enough to cover its annual cash burn of $12.58M.
  • CDLX has cash burn of 12577000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the CDLX balance sheet.

Negative Health Checks:

  • Total CDLX debt is higher than 5 years ago, relative to shareholder equity.
  • There are more long-term liabilities than short-term assets on the CDLX balance sheet.
  • CDLX has a relatively high debt to equity ratio of 3.26.
  • CDLX profit margin has gone up by 1.12 percentage points in the past year, but the company is still unprofitable.

Do analysts think it's a good time to buy Cardlytics stock

Out of 3 sell side analysts who give ratings on CDLX, the consensus analyst rating on Cardlytics is a Strong Buy

Please note that analyst ratings are not recommendations, nor are they investment advice.

You can dig deeper into what analysts are saying on the Cardlytics stock forecast page.

CDLX Technicals

SMA10
15.1
SMA20
11.52
SMA50
8.71
SMA100
8.57
SMA200
10.27
MACD
2.17
MACD Signal
1.89
MACD Histogram
0.28
RSI
58.5
Stochastic %K
51.84
Stochastic %D
66.02
StochRSI %K
10.42
StochRSI %D
39.91

CDLX Growth Numbers

Last year, CDLX revenue was $309.20M. Over the last five year, CDLX's revenue has gone up by 15.46% per year. This was faster than the Advertising Agencies industry average of 3.59%.

Dig into CDLX's earnings and revenue performance here.

Are CDLX insiders buying or selling the stock?

Over the past year, executives and large shareholders at CDLX have bought more shares than they have sold.

Clifford Sosin, 10% Owner of CDLX, was the latest CDLX insider to buy. They bought $4,956,000.00 worth of CDLX stock on Mar 19, 2024.

Get more info about who owns CDLX shares here.

Does CDLX stock generate passive income?

No, Cardlytics doesn't provide an income stream by paying out dividends.

CDLX Social Trading Data

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Make your CDLX buy order

There are two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are usually the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a given price limit, place a limit order.

Press the Open button and your broker will place the order.

If you need additional assistance investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get updates on your investment in CDLX

Now that you own some shares in CDLX, you'll want to keep up with your shares.

Put CDLX on a watchlist to track the latest developments regarding your CDLX stock.

CDLX Feed

How to Buy Stock in Cardlytics

To reiterate, here are the 6 steps to buy stock in Cardlytics:

  1. Decide where to buy Cardlytics stock
  2. Open a brokerage account
  3. Fund your brokerage account
  4. Analyze Cardlytics stock
  5. Make your CDLX buy order
  6. Get updates on your investment in CDLX

If you require a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get the latest news on your investment in Cardlytics, click below.

NASDAQ: CDLX
$14.49-0.15 (-1.02%)
Updated Mar 28, 2024
Open eToro Account
NASDAQ: CDLX
$14.49-0.15 (-1.02%)
Updated Mar 28, 2024
Open eToro Account

FAQ

How much does it cost to buy one Cardlytics share?

As of Mar 28, 2024, it costs $14.49 to buy one share of Cardlytics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $7, you can buy 0.483 shares of CDLX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Cardlytics stock?

According to 3 Wall Street analysts who monitor Cardlytics, their consensus recommendation is to buy Cardlytics stock.

What is the best way to buy Cardlytics stock?

One way to place an order for Cardlytics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.